Absci to report hair loss trial data next month
Absci dosing participants in hair loss trial; expects same month data. Hair loss drug program is advancing as company appoints new executive.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed